Global Canine Parvovirus Enteritis Market, By Diagnosis (Diagnostic Imaging, Serology, Physical Examination and Others), Treatment (Fluid Therapy, Antibiotic Treatment, Anti-Viral Treatments and Miscellaneous), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Canine Parvovirus Enteritis Market Analysis and Size
Canine parvovirus enteritis is the leading cause of morbidity and mortality in dogs worldwide. The incubation period following natural or experimental exposure ranges from around 4 to 14 days, and virus shedding starts a few days due to the incidence of clinical signs, progressively decreasing 3–4 weeks post-exposure. Abdominal radiography or ultrasonography detects largely nonspecific changes, including fluid- and gas-filled intestinal loops, hypo-motile intestines, and possibly thinning of mucosal layers. Treatment for parvovirus enteritis is largely supportive and symptomatic.
Data Bridge Market Research analyses a growth rate in the global canine parvovirus enteritis market in the forecast period 2023-2030. The expected CAGR of the global canine parvovirus enteritis market tends to be around 5% in the mentioned forecast period. The market was valued at USD 500 million in 2022 and would grow to USD 738.73 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Canine Parvovirus Enteritis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnosis (Diagnostic Imaging, Serology, Physical Examination, and Others), Treatment (Fluid Therapy, Antibiotic Treatment, Anti-Viral Treatments, and Miscellaneous), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Novasep (France), BASF SE (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH (Germany), DSM (Netherlands), Elanco (U.S.), Zoetis (U.S.)
|
|
Market Opportunities
|
|
Market Definition
A canine parvovirus is a highly contagious virus that leads to gastrointestinal disorders in unvaccinated dogs. It is a single-stranded DNA virus with a strong resistance to many common detergents and disinfectants. The virus can continue indoors at room temperature for the time of at least two months, and outdoors, if protected from sunlight, it can stay for many months and years. The major symptoms include anorexia, vomiting, diarrhea, and lethargy; therefore, the disease requires very specific treatment.
Global Canine Parvovirus Enteritis Market Dynamics
Drivers
- Increasing Demand for Diagnostic Tests
The rising demand for different diagnostic tests such as abdominal radiography or ultrasonography in detecting largely nonspecific changes, including fluid- and gas-filled intestinal loops, boost the market's growth.
- Increase in the Number of R&D Activities
An increase in the number of R&D activities push the market's growth. This will provide many beneficial opportunities for the market. To motivate researchers and pharmaceutical companies to develop novel medicines, the government funds multiple research and development (R&D) initiatives.
Opportunities
- Introduction of Diversified Treatment Methods
The rising introduction of varied treatment methods such as fluid therapy, antibiotic treatment, antiemetic treatment, and nutritional therapies creates more opportunities for market growth.
- Increasing Demand for Retail Pharmacies
The increase in the number of drugs for canine parvovirus enteritis that is delivered through retail pharmacies and the surge in the number of pharmacies in several developed countries create opportunities for market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily viable.
Restraints/Challenges
- Lack of Skilled Professionals
A lack of trained professionals who are unaware of the treatment methods for this disease could limit the growth of the global canine parvovirus enteritis market during the forecast period.
- Unavailability of Appropriate Treatments
To treat rare conditions, treatments are sometimes not available, particularly in underdeveloped countries, even for these conditions. Some conditions demand to be treated with advanced techniques, but these are sometimes unavailable in hospitals and clinics. Thus, it hampers market growth.
This global canine parvovirus enteritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global canine parvovirus enteritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Canine Parvovirus Enteritis Market Scope
The global canine parvovirus enteritis market is segmented on the basis of diagnosis, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
- Diagnostic Imaging
- Serology
- Physical Examination
- Others
Treatment
- Fluid Therapy
- Antibiotic Treatment
- Anti-Viral Treatments
- Miscellaneous
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Canine Parvovirus Enteritis Market Regional Analysis/Insights
The global canine parvovirus enteritis market is analyzed and market size insights and trends are provided by diagnosis, treatment, distribution channel and end-user as referenced above.
The major countries covered in the global canine parvovirus enteritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to have the highest market growth due to increased new research and developments in the canine parvovirus enteritis market.
North America dominates the market due to the presence of several major manufacturers and to increased new research and developments in the canine parvovirus enteritis market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Canine Parvovirus Enteritis Market Share Analysis
The global canine parvovirus enteritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global canine parvovirus enteritis market.
Key players operating in the global canine parvovirus enteritis market include:
- Novasep (France)
- BASF SE (U.S.)
- Bayer AG (Germany)
- Boehringer Ingelheim International GmbH (Germany)
- DSM (Netherlands)
- Elanco (U.S.)
- Zoetis (U.S.)
SKU-